Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2008 1
2009 1
2010 2
2011 5
2012 3
2013 2
2014 8
2015 6
2016 9
2017 9
2018 7
2019 9
2020 3
2021 1
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic viruses: a new class of immunotherapy drugs.
Kaufman HL, Kohlhapp FJ, Zloza A. Kaufman HL, et al. Among authors: zloza a. Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663. Nat Rev Drug Discov. 2015. PMID: 26323545 Free PMC article. Review.
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
Newman JH, Chesson CB, Herzog NL, Bommareddy PK, Aspromonte SM, Pepe R, Estupinian R, Aboelatta MM, Buddhadev S, Tarabichi S, Lee M, Li S, Medina DJ, Giurini EF, Gupta KH, Guevara-Aleman G, Rossi M, Nowicki C, Abed A, Goldufsky JW, Broucek JR, Redondo RE, Rotter D, Jhawar SR, Wang SJ, Kohlhapp FJ, Kaufman HL, Thomas PG, Gupta V, Kuzel TM, Reiser J, Paras J, Kane MP, Singer EA, Malhotra J, Denzin LK, Sant'Angelo DB, Rabson AB, Lee LY, Lasfar A, Langenfeld J, Schenkel JM, Fidler MJ, Ruiz ES, Marzo AL, Rudra JS, Silk AW, Zloza A. Newman JH, et al. Among authors: zloza a. Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1119-1128. doi: 10.1073/pnas.1904022116. Epub 2019 Dec 30. Proc Natl Acad Sci U S A. 2020. PMID: 31888983 Free PMC article.
Infection: a Cause of and Cure for Cancer.
Newman JH, Zloza A. Newman JH, et al. Among authors: zloza a. Curr Pharmacol Rep. 2017;3(6):315-320. doi: 10.1007/s40495-017-0109-y. Epub 2017 Oct 5. Curr Pharmacol Rep. 2017. PMID: 29201631 Free PMC article. Review.
Interferon Lambda: Toward a Dual Role in Cancer.
Lasfar A, Zloza A, Silk AW, Lee LY, Cohen-Solal KA. Lasfar A, et al. Among authors: zloza a. J Interferon Cytokine Res. 2019 Jan;39(1):22-29. doi: 10.1089/jir.2018.0046. Epub 2018 Jul 18. J Interferon Cytokine Res. 2019. PMID: 30020822 Review.
Talimogene laherparepvec (T-VEC) as cancer immunotherapy.
Kohlhapp FJ, Zloza A, Kaufman HL. Kohlhapp FJ, et al. Among authors: zloza a. Drugs Today (Barc). 2015 Sep;51(9):549-58. doi: 10.1358/dot.2015.51.9.2383044. Drugs Today (Barc). 2015. PMID: 26488034 Review.
IFN-lambda therapy: current status and future perspectives.
Lasfar A, Zloza A, Cohen-Solal KA. Lasfar A, et al. Among authors: zloza a. Drug Discov Today. 2016 Jan;21(1):167-171. doi: 10.1016/j.drudis.2015.10.021. Epub 2015 Nov 10. Drug Discov Today. 2016. PMID: 26552337 Review.
IFN-λ cancer immunotherapy: new kid on the block.
Lasfar A, Gogas H, Zloza A, Kaufman HL, Kirkwood JM. Lasfar A, et al. Among authors: zloza a. Immunotherapy. 2016 Jul;8(8):877-88. doi: 10.2217/imt-2015-0021. Immunotherapy. 2016. PMID: 27381684 Free PMC article. Review.
62 results